FDA Approved: Cuvrior for Wilson Disease
https://unsplash.com/photos/_jbClosDsD4

FDA Approved: Cuvrior for Wilson Disease

For the last 52 years, individuals with Wilson disease have been relying, largely, on the same treatment options. These options, designed to remove copper from the body, include Cuprimine (penicillamine).…

Continue Reading FDA Approved: Cuvrior for Wilson Disease

New Technology Found To Be Better Treatment for Hereditary Tyrosinemia Type 1 and Wilson Disease

LogicBio Therapeutics has just presented preclinical data of their GeneRide platform. This data demonstrates that the GeneRide technology is valuable in methylmalonic acidemia (MMA), hereditary tyrosinemia type 1 (HT1), and…

Continue Reading New Technology Found To Be Better Treatment for Hereditary Tyrosinemia Type 1 and Wilson Disease
New Data Available for GSD1a, OTC Deficiency, and Wilson Disease Studies
qimono / Pixabay

New Data Available for GSD1a, OTC Deficiency, and Wilson Disease Studies

  In a recent press release, biopharmaceutical company Ultragenyx Pharmaceutical Inc. ("Ultragenyx") shared positive safety and efficacy data from Phase 1/2 clinical trials on gene therapy solutions for ornithine transcarbamylase…

Continue Reading New Data Available for GSD1a, OTC Deficiency, and Wilson Disease Studies

Editor’s Choice: Adult Faces of Rare and Kids with SCID

Happy Friday Patient Worthians! We have two intriguing stories from PW contributors this week, detailing their plight with rare disease. Additionally, we have a pretty cool outcome for a pretty cool kid…

Continue Reading Editor’s Choice: Adult Faces of Rare and Kids with SCID